116 results
Page 2 of 6
POS AM
9y53twj
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
oer06rf gf
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
f217ww4vbs1tzu11b
11 May 22
Current report (foreign)
4:30pm
6-K
cxpfj o8z
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
6-K
y8acp
31 Mar 22
Results of General Meeting
8:41am
6-K
jyatm5x yyj04
16 Mar 22
Current report (foreign)
8:30am
6-K
ah4pvf8b
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
t465te
28 Feb 22
Amryt Receives Complete Response Letter from the FDA for Oleogel-S10 NDA
12:00pm
6-K
1bopzy5dcg
25 Feb 22
Current report (foreign)
4:05pm
6-K
o0ugpy 7czo88dr
31 Jan 22
Current report (foreign)
7:32am
6-K
9s6 v1ra5bob6c4zp
23 Nov 21
Amryt Provides Update on Regulatory Review Process for Oleogel-S1
8:04am
424B3
v3icd 8gklvfxu
22 Nov 21
Prospectus supplement
7:39am
424B3
savz9j6scqednatev
22 Nov 21
Prospectus supplement
7:38am
6-K
vqtkgvd ma6kpmx
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
6-K
EX-99.3
nhlu6 paj7
22 Nov 21
Amryt Announces the Cancellation of Admission of its Ordinary Shares to Trading on AIM
7:37am
424B3
1plr7t
3 Nov 21
Prospectus supplement
7:33am
424B3
g7s0hq
3 Nov 21
Prospectus supplement
7:32am
6-K
zpy664cikwoatl
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
92mftnr a226w
29 Oct 21
Current report (foreign)
6:05am